Renaissance Technologies »

Eikon Therapeutics shares owned by Renaissance Technologies

Quarter-by-quarter ownership of Eikon Therapeutics (EIKN) shares owned by Renaissance Technologies from 13F filings

Historical chart of Renaissance Technologies investment in Eikon Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Eikon Therapeutics held by Renaissance Technologies consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Eikon Therapeutics by Renaissance Technologies

Quarter filed Position value Share count Share price at filing
2026-06-30 $350k 27k 13.05

More positions owned by Renaissance Technologies

NVIDIA Corporation (NVDA)
Meta Platforms Cl A (META)
Intel Corporation (INTC)
United Therapeutics Corporation (UTHR)
Palantir Technologies Cl A (PLTR)
Alphabet Cap Stk Cl A (GOOGL)
Exelixis (EXEL)
Verisign (VRSN)
Kinross Gold Corp (KGC)
Crowdstrike Hldgs Cl A (CRWD)
Sterling Construction Company (STRL)
Alphabet Cap Stk Cl C (GOOG)
Amazon (AMZN)
Argan (AGX)
Netflix (NFLX)

View all positions for Renaissance Technologies

Top funds holding Eikon Therapeutics

FMR
BlackRock
Foresite Capital Management IV
Merck & Co
Foresite Capital Management V
Capital World Investors
T. Rowe Price Associates
Vanguard Capital Management
EcoR1 Capital
Alliancebernstein
Geode Capital Management
Baker Bros. Advisors
Soros Capital Management
StepStone
Canada Pension Plan Investment Board

View all funds holding Eikon Therapeutics